A Walking Intervention Among Men With Prostate Cancer: A Pilot Study

Clinical Genitourinary Cancer

Volumn 15, Issue 6, 2017, Pages e1021-e1028

  Pernar, Claire H ^a   Fall, Katja ^b   Rider, Jennifer R ^c   Markt, Sarah C ^a   Adami, Hans Olov ^a,d   Andersson, Sven Olof ^b   Valdimarsdottir, Unnur ^a,d,e   Andrén, Ove ^b   Mucci, Lorelei A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b ÖREBRO UNIVERSITY   (Sweden)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Biomarkers; Cardiovascular health; Exercise; Quality of life; Randomized trial

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOVASCULAR FUNCTION; CHARLSON COMORBIDITY INDEX; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEASIBILITY STUDY; GLEASON SCORE; HUMAN; MALE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PILOT STUDY; PROSTATE CANCER; PROSTATE SURGERY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SWEDEN; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; UNIVERSITY HOSPITAL; WAIST CIRCUMFERENCE; WALKING; WEIGHT REDUCTION; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; KINESIOTHERAPY; MIDDLE AGED; PROCEDURES; PROSTATE TUMOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; CARDIOVASCULAR DISEASES; EXERCISE THERAPY; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME; WALKING;

EID: 85021299019     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2017.05.022     Document Type: Article

References (38)

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
2. Ferlay, J., Soerjomataram, I., Dikshit, R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
3. Rider, J.R., Sandin, F., Andren, O., Wiklund, P., Hugosson, J., Stattin, P., Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol 63 (2013), 88–96.
4. Epstein, M.M., Edgren, G., Rider, J.R., Mucci, L.A., Adami, H.O., Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst 104 (2012), 1335–1342.
5. Sanda, M.G., Dunn, R.L., Michalski, J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358 (2008), 1250–1261.
6. Steineck, G., Helgesen, F., Adolfsson, J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002), 790–796.
7. Gomella, L.G., Johannes, J., Trabulsi, E.J., Current prostate cancer treatments: effect on quality of life. Urology 73 (2009), S28–S35.
8. Fall, K., Fang, F., Mucci, L.A., et al. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med, 6, 2009, e1000197.
9. Fang, F., Keating, N.L., Mucci, L.A., et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst 102 (2010), 307–314.
10. Bourke, L., Doll, H., Crank, H., Daley, A., Rosario, D., Saxton, J.M., Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 20 (2011), 647–657.
11. Holmes, M.D., Chen, W.Y., Feskanich, D., Kroenke, C.H., Colditz, G.A., Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005), 2479–2486.
12. Kenfield, S.A., Stampfer, M.J., Giovannucci, E., Chan, J.M., Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29 (2011), 726–732.
13. Meyerhardt, J.A., Giovannucci, E.L., Holmes, M.D., et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24 (2006), 3527–3534.
14. Richman, E.L., Kenfield, S.A., Stampfer, M.J., Paciorek, A., Carroll, P.R., Chan, J.M., Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71 (2011), 3889–3895.
15. Bonn, S.E., Sjolander, A., Lagerros, Y.T., et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev 24 (2015), 57–64.
16. Overgard, M., Angelsen, A., Lydersen, S., Morkved, S., Does physiotherapist-guided pelvic floor muscle training reduce urinary incontinence after radical prostatectomy? A randomised controlled trial. Eur Urol 54 (2008), 438–448.
17. Centemero, A., Rigatti, L., Giraudo, D., et al. Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study. Eur Urol 57 (2010), 1039–1043.
18. Galvao, D.A., Taaffe, D.R., Spry, N., Joseph, D., Newton, R.U., Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28 (2010), 340–347.
19. Culos-Reed, S.N., Robinson, J.W., Lau, H., et al. Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer 18 (2010), 591–599.
20. Gjerset, G.M., Fossa, S.D., Dahl, A.A., Loge, J.H., Ensby, T., Thorsen, L., Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients. J Cancer Educ 26 (2011), 754–760.
21. Park, S.W., Kim, T.N., Nam, J.K., et al. Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study. Urology 80 (2012), 299–305.
22. Craft, L.L., Vaniterson, E.H., Helenowski, I.B., Rademaker, A.W., Courneya, K.S., Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21 (2012), 3–19.
23. Demark-Wahnefried, W., Aziz, N.M., Rowland, J.H., Pinto, B.M., Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23 (2005), 5814–5830.
24. Cohen, S., Kamarck, T., Mermelstein, R., A global measure of perceived stress. J Health Soc Behav 24 (1983), 385–396.
25. Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
26. Nordin, M., Akerstedt, T., Nordin, S., Psychometric evaluation and normative data for the Karolinska Sleep Questionnaire. Sleep Biol Rhythms 11 (2013), 216–226.
27. Van Hemelrijck, M., Wigertz, A., Sandin, F., et al. Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol 42 (2013), 956–967.
28. Ewald, B., Attia, J., McElduff, P., How many steps are enough? Dose-response curves for pedometer steps and multiple health markers in a community-based sample of older Australians. J Phys Act Health 11 (2014), 509–518.
29. Tudor-Locke, C., Bassett, D.R. Jr., How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 34 (2004), 1–8.
30. Hansen, P.A., Dechet, C.B., Porucznik, C.A., LaStayo, P.C., Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. PM R 1 (2009), 1019–1024.
31. Segal, R.J., Reid, R.D., Courneya, K.S., et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27 (2009), 344–351.
32. Galvao, D.A., Spry, N., Denham, J., et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 65 (2014), 856–864.
33. Jones, L.W., Hornsby, W.E., Freedland, S.J., et al. Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. Eur Urol 65 (2014), 852–855.
34. Basaria, S., Lieb, J. 2nd, Tang, A.M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) 56 (2002), 779–786.
35. Monga, U., Garber, S.L., Thornby, J., et al. Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil 88 (2007), 1416–1422.
36. Carmack Taylor, C.L., de Moor, C., Basen-Engquist, K., et al. Moderator analyses of participants in the Active for Life after cancer trial: implications for physical activity group intervention studies. Ann Behav Med 33 (2007), 99–104.
37. Windsor, P.M., Nicol, K.F., Potter, J., A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101 (2004), 550–557.
38. Nguyen, P.L., Alibhai, S.M., Basaria, S., et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67 (2015), 825–836.